Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.
about
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer.Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortInterpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservativelyAn empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detectionProstate cancer screening and determining the appropriate prostate-specific antigen cutoff values.Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in ChinaChanges in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population.Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients.Prostate Cancer Screening.
P2860
Q33545711-F06E5C5A-298E-43A1-9A05-62A51ABA7AC8Q33558289-E0D2FE3F-1907-4A88-AED2-B8C6DF354E22Q33745069-B5DEDBB9-A6AE-400F-8AD1-D62F851CC6A3Q33937634-91FEC3FD-E959-4C22-9FEF-CE8EA9A169F6Q34086557-2AD045EE-412A-4E84-A3B1-AA81B5465E2DQ34332454-115F2621-A465-45AD-BBEA-9B6C9C04663DQ34677200-FF205247-A889-4BAE-9FEF-0AFEC28F2663Q35022732-FB19310E-7568-466E-AC0A-65368468248EQ37074759-9C6B5603-673C-4B3B-9EA9-088A22859256Q46022495-93C2ECDB-3577-410A-8BF7-C274DDDA2E69Q47718669-DFD17AA3-81E6-437E-8DE5-FDC0786C25D2Q52698894-EE28B335-5007-44EA-931E-D8B0F7573ADD
P2860
Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Relationship of prostate-speci ...... tate cancer screening program.
@en
Relationship of prostate-speci ...... tate cancer screening program.
@nl
type
label
Relationship of prostate-speci ...... tate cancer screening program.
@en
Relationship of prostate-speci ...... tate cancer screening program.
@nl
prefLabel
Relationship of prostate-speci ...... tate cancer screening program.
@en
Relationship of prostate-speci ...... tate cancer screening program.
@nl
P2093
P1433
P1476
Relationship of prostate-speci ...... tate cancer screening program.
@en
P2093
Kimberly A Roehl
Ofer Yossepowitch
Scott E Eggener
William J Catalona
Xiaoying Yu
P304
P356
10.1016/J.UROLOGY.2007.12.008
P407
P50
P577
2008-03-21T00:00:00Z